Search hospitals > Quebec > SHERBROOKE
Centre de Recherche du CHUS
Claim this profileSHERBROOKE, Quebec J1H 5N4
Conducts research for Type 2 Diabetes
Conducts research for Obesity
Conducts research for Prediabetes
Conducts research for Ketoacidosis
Conducts research for Healthy Adults
39 reported clinical trials
6 medical researchers
Summary
Centre de Recherche du CHUS is a medical facility located in SHERBROOKE, Quebec. This center is recognized for care of Type 2 Diabetes, Obesity, Prediabetes, Ketoacidosis, Healthy Adults and other specialties. Centre de Recherche du CHUS is involved with conducting 39 clinical trials across 65 conditions. There are 6 research doctors associated with this hospital, such as Éric Turcotte, MD, Mélanie Morin, PT, PhD, Andre Carpentier, and Denis Blondin.Top PIs
Éric Turcotte, MDCentre de recherche du CHUS1 year of reported clinical research
Studies Traumatic Arthropathy
Studies Bone Cancer
6 reported clinical trials
9 drugs studied
Mélanie Morin, PT, PhDCentre de Recherche du Centre Hospitalier Universitaire de Sherbrooke7 years of reported clinical research
Studies Dyspareunia
Studies Gynecological Cancers
2 reported clinical trials
1 drug studied
Andre CarpentierCentre intégré universitaire de santé et de services sociaux de l'Estrie Centre Hospitalier Universitaire de Sherbrooke (CIUSSS de lEstrie-CHUS)6 years of reported clinical research
Studies Type 1 Diabetes
Studies Diabetes
2 reported clinical trials
5 drugs studied
Denis BlondinCentre de recherche du CHUS4 years of reported clinical research
Studies Type 2 Diabetes
Studies Incretin Hormones in Polycystic Ovary Syndrome
2 reported clinical trials
3 drugs studied
Clinical Trials running at Centre de Recherche du CHUS
Type 2 Diabetes
Pregnancy Complications
Obesity
Health Behaviors
Renal Cyst
Breast cancer
Breast Cancer
Diabetes
Incretin Hormones in Polycystic Ovary Syndrome
Prediabetes
Brown Fat Activation Treatments
for Type 2 Diabetes
Activation of brown adipose tissue (BAT) by cold exposure. BAT thermogenesis and BAT volume of metabolic activity will be assessed by Positron-Emitting-Tomography (PET/CT) and MRI/MRS imaging and new pharmacological methods to modulate BAT thermogenesis. All previous data on the functioning of Brown Adipose Tissue (BAT) were obtained by Positron-Emitting-Tomography (PET) imaging studies using fluorodeoxyglucose F18 ( \[18F\]- FDG). This approach underestimates the actual activity of the BAT. In this study, the investigator is going to use a new PET tracer (C11-palmitate) which is a fat molecule. This will allow to quantify more accurately the activity of brown fat.
Recruiting3 awards N/A2 criteria
Bariatric Surgery
for Type 2 Diabetes
The present protocol aims to understand and establish whether there is a causal link between adipose tissue metabolic remodeling and Type 2 Diabetes (T2D) remission after bariatric surgery. All participants will have a bariatric surgery, divided in 2 groups: with or without T2D.
Recruiting1 award N/A5 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Centre de Recherche du CHUS?
Centre de Recherche du CHUS is a medical facility located in SHERBROOKE, Quebec. This center is recognized for care of Type 2 Diabetes, Obesity, Prediabetes, Ketoacidosis, Healthy Adults and other specialties. Centre de Recherche du CHUS is involved with conducting 39 clinical trials across 65 conditions. There are 6 research doctors associated with this hospital, such as Éric Turcotte, MD, Mélanie Morin, PT, PhD, Andre Carpentier, and Denis Blondin.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.